To hear about similar clinical trials, please enter your email below
Trial Title:
Pre-operative Therapy in Breast Cancer
NCT ID:
NCT05621564
Condition:
Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Other
Intervention:
Intervention type:
Drug
Intervention name:
pre-operative therapy
Description:
pre-operative therapy includes pre-operative chemotherapy, radiation, endocrine therapy,
target therapy and other anti-tumor therapy
Arm group label:
advanced breast cancer
Arm group label:
early breast cancer
Summary:
This is a prospective and retrospective study to evaluate the effect of pre-operative
therapy on response and survival, and compare the difference in response and survival by
pre-operative regimen or by patient's clinicopathological characteristic in early or
advanced breast cancer.
Criteria for eligibility:
Study pop:
The study population will be selected from the hospital where they are treated
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Female, Aged ≥18 years
- Histologically confirmed primary breast cancer
- Plan to receive pre-operative therapy
- Adequate organ function
Exclusion Criteria:
- History of neurological or psychological disease, including epilepsy or dementia
- Not suitable to participate in this study judged by investigators
Gender:
Female
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Address:
City:
Shanghai
Zip:
200127
Country:
China
Status:
Recruiting
Contact:
Last name:
Wenjin Yin
Phone:
86(21)68385569
Email:
yinwenjin@renji.com
Start date:
November 1, 2022
Completion date:
November 2030
Lead sponsor:
Agency:
RenJi Hospital
Agency class:
Other
Source:
RenJi Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05621564
